Paying patient and public reviewers: is The BMJ’s bold move justified?
The BMJ will now pay patient and public reviewers. Learn why this move matters for diversity in patient engagement and the future of medical publishing.
Four factors that influence patient and public involvement in health research
Find out the factors that impact on the likelihood of patient and public involvement in health research.
CHEERS 2022 statement: reporting guidance for health economic evaluations gets a makeover
Read about the new 28-item checklist developed to aid decision-making in health economic evaluations.
Division among Cochrane members: what does the future hold?
Cochrane members have become divided over growing centralisation of the organisation. An article in The BMJ explores the question, “Has Cochrane lost its way?”.
Meeting report: summary of day 1 of the 2019 European ISMPP Meeting
Missed ISMPP EU 2019? Read our meeting report to get up to speed!
Patient partnerships: what can other journals learn from The BMJ?
The BMJ uses its experience with patient partnerships to encourage other journals to increase patient involvement.
New EU trials tracker reveals that half of European clinical trials have broken reporting rules
Is your institute breaking European clinical trial reporting rules? Find out using the new EU trials tracker, part of the AllTrials initiative.
The disparity between top-tier journals and their smaller counterparts: should we be worried?
In a recent opinion piece for The BMJ, Dr Elizabeth Loder describes the potential impact of the resource gap between top- and lower-tier journals.
Can the lay public enhance peer review?
Researchers argue that lay review will increase the relevance of medical publications: a new study aims to evaluate its impact.